Sirolimus for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over (terminated appraisal) (TA972)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 27 January 2026Published: 22 May 2024
Depemokimab for treating chronic rhinosinusitis with nasal polyps in adults (terminated appraisal) (TA1123)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 January 2026
Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen (TA1087)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 August 2025
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (TA1045)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 March 2025
Hearing loss in adults: assessment and management (NG98)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 21 June 2018
Otitis media with effusion in under 12s (NG233)Product type:GuidanceProgramme:NICE guidelinePublished: 30 August 2023
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal) (TA847)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 November 2022
Otitis media (acute): antimicrobial prescribing (NG91)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 March 2022Published: 28 March 2018
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome (TA139)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 20 August 2021Published: 26 March 2008
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) (TA678)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 February 2021
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) (TA648)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 September 2020
Tinnitus: assessment and management (NG155)Product type:GuidanceProgramme:NICE guidelinePublished: 11 March 2020
Rapid tests for group A streptococcal infections in people with a sore throat (HTG531)Product type:GuidanceProgramme:HealthTech guidancePublished: 13 November 2019
Cochlear implants for children and adults with severe to profound deafness (TA566)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 7 March 2019
Sore throat (acute): antimicrobial prescribing (NG84)Product type:GuidanceProgramme:NICE guidelinePublished: 26 January 2018
Sinusitis (acute): antimicrobial prescribing (NG79)Product type:GuidanceProgramme:NICE guidelinePublished: 27 October 2017
XprESS multi sinus dilation system for treating chronic sinusitis (HTG424)Product type:GuidanceProgramme:HealthTech guidancePublished: 13 December 2016
Ambu aScope 4 RhinoLaryngo for visualising upper airways during rhinolaryngoscopy (MIB316)Product type:AdviceProgramme:Medtech innovation briefingPublished: 14 February 2023
PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)Product type:AdviceProgramme:Medtech innovation briefingPublished: 9 February 2021
SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea (MIB190)Product type:AdviceProgramme:Medtech innovation briefingPublished: 9 September 2019
TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum (MIB134)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 January 2018
Otovent nasal balloon for otitis media with effusion (MIB59)Product type:AdviceProgramme:Medtech innovation briefingPublished: 15 March 2016
Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitus (MIB5)Product type:AdviceProgramme:Medtech innovation briefingPublished: 10 June 2014
Dupilumab for treating severe chronic rhinosinusitis with nasal polyps (review of TA648) [ID6480]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 18 February 2026
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years [ID6537]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 26 August 2026
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps ID6379Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 9 September 2026
Hearing aids for adults with hearing lossStatus:In developmentProgramme:Health technology evaluationExpected publication date: 27 January 2027
STG320 for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites [ID1278]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social careStatus:Awaiting developmentExpected publication date: TBC
Benralizumab for previously treated severe nasal polyps [ID1659]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Electrosurgery (diathermy and coblation) for tonsillectomyStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Hyaluronic acid injection in periprosthetic leakage / pharyngocutaneous fistula in patients with voice prosthesis in post-laryngectomy patientsStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysfunction (RCPD)Status:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Polydioxanone stents for the therapy of Tracheal stenosis: adultsStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Fibreoptic endoscopic evaluation of swallowing (FEES)Status:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
PROPEL (mometasone furoate implant, 370ug) MT578 (MIB253)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Electrosurgery (diathermy and coblation) for tonsillectomy, (IP324/2)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
AHEAD implants for external ear prosthesisStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Digital tools and platforms to support the early detection and initial diagnosis of hearing lossStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Mercaptamine hydrochloride for treating corneal cystine crystal deposits in people 6 months to under 2 years with cystinosis [TSID12261]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
DB-OTO for Hearing loss [ID6728]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC